Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2022-07-11
5:27 pm
Sale
13DEntasis Therapeutics Holdings Inc.
ETTX
Innoviva Inc.
INVA
100
100%
-57,345,694decrease
(-100.00%)
View
2022-05-23
8:55 pm
Unchanged
13DEntasis Therapeutics Holdings Inc.
ETTX
Innoviva Inc.
INVA
57,345,794
74.93%
0
(Unchanged)
View
2022-03-15
09:00 am
Unchanged
13DEntasis Therapeutics Holdings Inc.
ETTX
Innoviva Inc.
INVA
57,345,794
74.93%
0
(Unchanged)
View
2022-02-18
8:47 pm
Unchanged
13DEntasis Therapeutics Holdings Inc.
ETTX
Innoviva Inc.
INVA
57,345,794
75.15%
0
(Unchanged)
View
2022-02-14
11:43 am
Sale
13GEntasis Therapeutics Holdings Inc.
ETTX
EVENTIDE ASSET MANAGEMENT LLC590,602
1.2%
-288,939decrease
(-32.85%)
View
2022-02-01
6:34 pm
Unchanged
13DEntasis Therapeutics Holdings Inc.
ETTX
Innoviva Inc.
INVA
57,345,794
75.15%
0
(Unchanged)
View
2022-01-18
5:27 pm
Purchase
13DEntasis Therapeutics Holdings Inc.
ETTX
TPG GP A LLC1,020,748
2.1%
1,020,748increase
(New Position)
View
2021-06-11
5:37 pm
Purchase
13DEntasis Therapeutics Holdings Inc.
ETTX
Innoviva Inc.
INVA
57,345,794
75.5%
12,537,950increase
(+27.98%)
View
2021-05-03
5:19 pm
Purchase
13DEntasis Therapeutics Holdings Inc.
ETTX
Innoviva Inc.
INVA
44,807,844
70.6%
7,462,050increase
(+19.98%)
View
2021-03-04
06:17 am
Sale
13DEntasis Therapeutics Holdings Inc.
ETTX
Sofinnova Venture Partners IX L.P.0
0%
-1,180,178decrease
(Position Closed)
View
2021-02-16
3:07 pm
Sale
13GEntasis Therapeutics Holdings Inc.
ETTX
ARMISTICE CAPITAL LLC1,863,198
4.99%
-1,647,783decrease
(-46.93%)
View
2020-09-08
4:29 pm
Purchase
13GEntasis Therapeutics Holdings Inc.
ETTX
ARMISTICE CAPITAL LLC3,510,981
9.9%
3,510,981increase
(New Position)
View
2020-09-01
5:28 pm
Purchase
13DEntasis Therapeutics Holdings Inc.
ETTX
Innoviva Inc.
INVA
37,345,794
69%
9,345,794increase
(+33.38%)
View
2020-08-31
3:10 pm
Unchanged
13DEntasis Therapeutics Holdings Inc.
ETTX
Innoviva Inc.
INVA
28,000,000
67.8%
0
(Unchanged)
View
2020-08-11
4:30 pm
Sale
13GEntasis Therapeutics Holdings Inc.
ETTX
Novo Holdings A/S1,173,896
4.3%
-1,007,947decrease
(-46.20%)
View
2020-07-09
4:48 pm
Sale
13DEntasis Therapeutics Holdings Inc.
ETTX
Clarus Lifesciences III L.P.1,339,836
4.9%
-283,569decrease
(-17.47%)
View
2020-06-18
12:30 pm
Sale
13DEntasis Therapeutics Holdings Inc.
ETTX
Frazier Life Sciences VIII L.P.799,953
2.9%
-250,000decrease
(-23.81%)
View
2020-06-16
1:54 pm
Unchanged
13GEntasis Therapeutics Holdings Inc.
ETTX
Novo Holdings A/S2,181,843
7.99%
0
(Unchanged)
View
2020-06-12
5:30 pm
Purchase
13DEntasis Therapeutics Holdings Inc.
ETTX
Innoviva Inc.
INVA
28,000,000
67.8%
25,354,980increase
(+958.59%)
View
2020-05-01
5:01 pm
Unchanged
13DEntasis Therapeutics Holdings Inc.
ETTX
Clarus Lifesciences III L.P.1,623,405
11.1%
0
(Unchanged)
View
Goto 0, 1, Next